Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 14, Issue 7, 2008, Pages 992-999

  Altschuler, Andrea ^a   Collins, Bernadette ^a   Lewis, James D ^b   Velayos, Fernando ^c   Allison, James E ^a,c   Hutfless, Susan ^a   Liu, Liyan ^a   Herrinton, Lisa J ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IBD; Organizational aspects of care; Practice variation

Indexed keywords

INFLIXIMAB;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; ENTERITIS; GASTROENTEROLOGY; HEALTH CARE DELIVERY; HEALTH EDUCATION; OBSERVATIONAL STUDY; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SELF REPORT; SEMI STRUCTURED INTERVIEW;

ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; COMPLEMENTARY THERAPIES; DECISION MAKING; GASTROENTEROLOGY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERVIEWS AS TOPIC; NURSES; PATIENT CARE; PATIENT EDUCATION AS TOPIC;

EID: 47949133405     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20416     Document Type: Article

References (29)

1. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992;14:309-317.
2. Longobardi T, Jacobs P, Bernstein CN. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Am J Gastroenterol. 2004;99: 650-655.
3. Hanauer SB, Sandborn W. Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2001;96:635-643.
4. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.
5. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology. 2003;125:1503-1507.
6. Whiteford MH, Kilkenny J 3rd, Hyman N, et al. The Standards Practice Task Force; the American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum. 2005;48:1337-1342.
7. Itzkowitz SH, Present DH. Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314-321.
8. Tremaine WJ, Sandborn WJ, Loftus EV, et al. A prospective cohort study of practice guidelines in inflammatory bowel disease. Am J Gastroenterology. 2001;96:2401-2406.
9. Polito JM, Childs B, Mellits ED, et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology,. 1996;111:580-586.
10. Lashner BA, Evans AA, Kirsner JB, et al. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology. 1986;91:1396-1400.
11. Katz S. Mind the gap: an unmet need for new therapy in IBD. J Clin Gastroenterol. 2007;41:799-809.
12. Brookes MJ, Green JR. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Drugs. 2004;64:1069-1089.
13. Eborall H, Davies R, Kinmonth AL, et al. Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomized controlled trial. BMJ. 2007; 335:490-493.
14. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293: 1197-1203.
15. Ziebland S, Chapple A, Dumelow C, et al. How the internet affects patients' experience of cancer: a qualitative study. BMJ. 2004;328:564-569.
16. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 2003;326:196-201.
17. Gallagher TH, Waterman AD, Ebers AG, et al. Patients' and physicians' attitudes regarding the disclosure of medical errors. JAMA. 2003;289: 1001-1007.
18. Beich A, Gannik D, Malterud K. Screening and brief intervention for excessive alcohol use: qualitative interview study of the experiences of general practitioners. BMJ. 2002;325:870-874.
19. Bradley EH, Holmboe ES, Mattera JA, et al. A qualitative study of increasing beta-blocker use after myocardial infarction. JAMA. 2001; 285:2604-2611.
20. Dixon-Woods M, Findlay M, Young B, et al. Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet. 2001;357:670-674.
21. Lavery JV, Boyle J, Dickens BM, et al. Origins of the desire for euthanasia and assisted suicide in people with HIV-1 or AIDS: a qualitative study. Lancet. 2001;358:362-367.
22. Singer PA, Martin DK, Keiner M. Quality end-of-life care. JAMA. 1999;281:163-168.
23. Lofland J, Lofland LH. Analyzing social settings: a guide to qualitative observation and analysis. Belmont, CA: Wadsworth; 2006.
24. Charmaz K. Grounded theory. In: Smith J, Harre R, Van Langenhove L, editors. Rethinking methods in psychology. London: Sage; 1995.
25. Oldenberg B, Hommes D. Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr Opin Gastroenterol. 2007;23: 395-399.
26. Baert F, Caprilli R, Angelucci E. Medical therapy for Crohn's disease: top-down or step-up? Dig Dis. 2007;25:260-266.
27. Hanauer SB. Clinical perspectives in Crohn's disease: turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down." Rev Gastroenterol Disord. 2007;7(Suppl 2):S17-22.
28. Su C. Outcomes of placebo therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:328-333.
29. Lewis JD. Anti-TNF antibodies for Crohn's disease - in pursuit of the perfect clinical trial. N Engl J Med. 2007;357:296-298.